|
Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda (Drugs@FDA)
DailyMed
Index to Drug-Specific Information
Chronological List of Approvals
Drug Approvals 1996-2002
Drug Approvals Prior to1996
New Drugs Approved for Cancer
Drug Approval Statistics
Drugs and Diseases
MedlinePlus
(National Library of Medicine)
Clinical Trials
Good
Clinical Practice
Participating in Clinical Trials (NIH)
Cancer
Clinical Trials (NIH)
Access to Unapproved Drugs
Office of
Special Health Issues
Generic Drugs
Office of Generic
Drugs Web page
Orange Book
Paragraph IV Patent Certifications
First-time Generics
Drug Availability
Drug Shortages
Drug
Recalls
Drug Safety
Public Health Advisories
Medication Guides
MedWatch
- Safety Information and Adverse Event Reporting
Consumer Education: What You Need to Know to Use Medicine Safely
Drug Identification
DDI Drug ID service
National Drug Code Directory
Publications
CDER 2007 Update: Improving Public Health Through Human Drugs
CDER Report to the Nation Archives
From Test Tube to Patient
|
 |
Imports and Buying Drugs on the Internet
FDA Import Policy
Importing
Prescription Drugs
Buying Medicines Online/Internet
Prescribing
Counterfeit Drugs
Reporting Illegal Sales of Medical Products on the
Internet
Federal Trade Commission Consumer Complaint Form
Dietary Supplements
Over-the-Counter (OTC) Medicines
OTC Home Page
OTC Rulemaking
Drug Registration and Listing
Drug Review Process
CDER Handbook
FDA Consumer Articles
Drug Approval Application Process
Small Business Assistance
Drug Development
Drug Applications
Pre-IND Consultation Contacts
Request for Single Patient or Emergency Use IND
CDER Organization Chart
Guidance for Industry
Guidance for Institutional Review
Boards (IRBs),
Clinical Investigators,
and Sponsors
Good Manufacturing Practice Regulations
Good Clinical Practice Questions and
Answers
Small Business Assistance
Code of Federal Regulations
United States Pharmacopeia
Additional
General Drug Information Links
|
 |
Hot Topics at CDER
Accutane and iPLEDGE
Antidepressant Warnings
Avandia
Anti-epileptic drugs
Chantix
COX-2 Inhibitors and NSAIDs
(including Bextra, Celebrex, and Vioxx)
ENHANCE Trial
Long Acting Beta Agonist Inhalers
(Serevent Diskus, Advair Diskus, and Foradil)
Mifeprex (RU-486)
New Requirements for Prescribing Information
Orlistat/Alli
Plan B
Tysabri
Zelnorm
Unapproved Drug Products
Drug Specific Safety Information
Additional Specific Drug Info
Archives
Links to State Boards and Organizations
State Boards of Pharmacy
Federation of State Medical Boards
American Medical Association
American Society of Health-Systems Pharmacists
Top Drug Information Questions
Frequently Asked Questions of DDI Staff
Frequently Asked
Questions to CDER
Frequently Requested FDA Telephone Numbers
Still can’t find the answer?
Visit the DDI home page.
Contact CDER’s Division of
Drug Information.
druginfo@fda.hhs.gov
1-888-INFO-FDA
1-888 463-6332 or (301) 796-3400
Division of Drug Information
10903 New Hampshire Avenue
WO51-2201
Silver Spring, MD 20993-0002 |
